Bulk Suggestion
Bulk ID:
mrvhyte/06.01.25-05:38AM
Accepted at: Jun, 10, 2025
12:49 a.m.
Related Deck:
1675118865074
Accepted
Rationale for new note
Additional cards on hypertension from eTG
Text
The first-line drug choice for management of hypertension in a patient with {{c1::Heart failure with reduced ejection fraction, CKD or post-MI::3}} is:
{{c2::ACEI or ARB}}
{{c2::ACEI or ARB}}
Text
The first-line drug choice for management of <b>hypertension</b> in a patient with {{c1::Heart failure with reduced ejection fraction, CKD or post-MI::3}} is:<br><br>{{c2::ACEI or ARB}}
Extra
Extra
<img src="0156aabd326256ff1bffcc71d6fbae10.webp">
Extra (Synced)
Empty field
Extra (Synced)
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
eTG Complete
eTG Complete
<img src="d3ee50aed7cf1767c81a317d02cb3f06.webp">
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Additional Resources (Synced)
Source
<a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=cardiovascular-disease-risk-stratification&guidelinename=auto§ionId=c_CVG_Hypertension-and-blood-pressure-reductiontopic_8#c_CVG_Hypertension-and-blood-pressure-reductiontopic_8">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=cardiovascular-disease-risk-stratification&guidelinename=auto&sectionId=c_CVG_Hypertension-and-blood-pressure-reductiontopic_8#c_CVG_Hypertension-and-blood-pressure-reductiontopic_8</a> Accessed Jun 1, 2025
One by one
Empty field
One by one
Tags
#Malleus_CM::#eTG_Complete::Cardiovascular::Blood_pressure_reduction::Hypertension_and_blood_pressure_reduction
#Malleus_CM::#Question_Banks::eMedici::0-999::60
#Malleus_CM::#Question_Banks::eMedici::1000-1999::1762
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Indigenous_Health
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Subjects::Cardiology::06_Vascular_Pathology::01_Hypertension::Essential_Hypertension::10_Management
#Malleus_CM::#Yield::High
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Captopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Enalapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fozinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fosinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Lisinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Perindopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Quinapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Ramipril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Trandolapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Candesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Eprosartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Drug::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Irbesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Losartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Olmesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Telmisartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Valsartan::03_Indications